Intensive Care Unit, Fujian Medical University Affiliated First Quanzhou Hospital, Quanzhou, Fujian, PR China.
Medicine (Baltimore). 2024 Oct 4;103(40):e39931. doi: 10.1097/MD.0000000000039931.
P/FP [PaO2/(FiO2*PEEP)] is associated with in-hospital mortality in patients with acute respiratory distress syndrome (ARDS). However, to the best of our knowledge, the association between P/FP after 24 hours of invasive mechanical ventilation (IMV) and in-hospital mortality in patients with ARDS due to Coronavirus Disease 2019 (COVID-19) remained unclear. This study aimed to evaluate the relationship between the P/FP after 24 hours of IMV and in-hospital mortality in patients with ARDS due to COVID-19. We reanalyzed previously published data from Peru. Hueda-Zavaleta et al conducted a retrospective cohort study between April 2020 and April 2021 in southern Peru. A total of 200 hospitalized COVID-19 patients requiring IMV were included in this analysis. We used Cox proportional hazard regression models and Kaplan-Meier survival analysis to investigate the effect of P/FP after 24 hours of IMV on in-hospital mortality. We used a restricted cubic spline regression and a two-piecewise Cox proportional hazards model to explore the relationship between P/FP after 24 hours of IMV and in-hospital mortality in patients with ARDS due to COVID-19. Of the 200 patients, 51 (25.50%) died in hospital. The median P/FP was 20.45 mm Hg/cmH2O [interquartile range 15.79-25.21 mm Hg/cmH2O], with a range of 5.67 mm Hg/cmH2O to 51.21 mm Hg/cmH2O. Based on the P/FP ratio, patients were equally divided into 2 groups (low group [P/FP < 20.50 mm Hg/cmH2O] and high group [P/FP ≥ 20.50 mm Hg/cmH2O]). In-hospital mortality was lower in the high P/FP group than in the low P/FP group (12 [12%] vs 39 [39%]; unadjusted hazard ratio [HR]: 0.33, 95% confidence interval [CI]: 0.17-0.63; adjusted HR: 0.10, 95% CI: 0.02-0.47). We also found a nonlinear relationship between P/FP and in-hospital mortality. After adjusting for potential confounders, the HR was 0.67 (95% CI: 0.56-0.79) for P/FP ≤ 22 mm Hg/cmH2O and 1.10 (95% CI: 0.83-1.47) for P/FP > 22 mm Hg/cmH2O. In addition, lymphocytes ≤ 1 × 109/L and acute kidney failure had a higher risk of death. After adjusting for potential confounders, the P/FP after 24 hours of IMV was nonlinearly associated with in-hospital mortality in patients with ARDS due to COVID-19.
P/FP(PaO2/(FiO2*PEEP))与急性呼吸窘迫综合征(ARDS)患者的住院死亡率相关。然而,据我们所知,COVID-19 引起的 ARDS 患者在接受 24 小时有创机械通气(IMV)后,P/FP 与住院死亡率之间的关系仍不清楚。本研究旨在评估 COVID-19 引起的 ARDS 患者在接受 24 小时 IMV 后 P/FP 与住院死亡率之间的关系。我们重新分析了来自秘鲁的先前发表的数据。Hueda-Zavaleta 等人于 2020 年 4 月至 2021 年 4 月在秘鲁南部进行了一项回顾性队列研究。这项分析纳入了 200 名需要 IMV 的 COVID-19 住院患者。我们使用 Cox 比例风险回归模型和 Kaplan-Meier 生存分析来研究 IMV 后 24 小时 P/FP 对住院死亡率的影响。我们使用限制性立方样条回归和两段式 Cox 比例风险模型来探讨 COVID-19 引起的 ARDS 患者 IMV 后 24 小时 P/FP 与住院死亡率之间的关系。在 200 名患者中,51 名(25.50%)在住院期间死亡。中位数 P/FP 为 20.45mm Hg/cmH2O[四分位距 15.79-25.21mm Hg/cmH2O],范围为 5.67mm Hg/cmH2O 至 51.21mm Hg/cmH2O。根据 P/FP 比值,患者被平均分为 2 组(低 P/FP 组[P/FP<20.50mm Hg/cmH2O]和高 P/FP 组[P/FP≥20.50mm Hg/cmH2O])。高 P/FP 组的住院死亡率低于低 P/FP 组(12[12%]vs39[39%];未调整的危险比[HR]:0.33,95%置信区间[CI]:0.17-0.63;调整后的 HR:0.10,95%CI:0.02-0.47)。我们还发现 P/FP 与住院死亡率之间存在非线性关系。在调整了潜在混杂因素后,P/FP≤22mm Hg/cmH2O 的 HR 为 0.67(95%CI:0.56-0.79),P/FP>22mm Hg/cmH2O 的 HR 为 1.10(95%CI:0.83-1.47)。此外,淋巴细胞≤1×109/L 和急性肾损伤与死亡风险更高相关。在调整了潜在混杂因素后,COVID-19 引起的 ARDS 患者在接受 24 小时 IMV 后,P/FP 与住院死亡率之间呈非线性关系。